Endometrial safety of ultra-low-dose estradiol vaginal tablets

James Simon; Lila Nachtigall; Lian G Ulrich; Michaela Eugster-Hausmann; Robert Gut

doi:10.1097/AOG.0b013e3181f386bb

Endometrial safety of ultra-low-dose estradiol vaginal tablets

James Simon, Lila Nachtigall, Lian G Ulrich, Michaela Eugster-Hausmann, Robert Gut

Institut for Klinisk Medicin

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

63 Citationer (Scopus)

Abstract

To evaluate the endometrial hyperplasia and carcinoma rate after 52-week treatment with ultra-low-dose 10-microgram 17ß-estradiol vaginal tablets in postmenopausal women with vaginal atrophy.

Originalsprog	Engelsk
Tidsskrift	Key Obstetrics and Gynecology
Vol/bind	116
Udgave nummer	4
Sider (fra-til)	876-83
Antal sider	8
DOI	https://doi.org/10.1097/AOG.0b013e3181f386bb
Status	Udgivet - 1 okt. 2010

Adgang til dokumentet

10.1097/AOG.0b013e3181f386bb

Citationsformater

@article{22369d78c040474988dbfd4852293c7f,

title = "Endometrial safety of ultra-low-dose estradiol vaginal tablets",

abstract = "To evaluate the endometrial hyperplasia and carcinoma rate after 52-week treatment with ultra-low-dose 10-microgram 17{\ss}-estradiol vaginal tablets in postmenopausal women with vaginal atrophy.",

author = "James Simon and Lila Nachtigall and Ulrich, {Lian G} and Michaela Eugster-Hausmann and Robert Gut",

year = "2010",

month = oct,

day = "1",

doi = "10.1097/AOG.0b013e3181f386bb",

language = "English",

volume = "116",

pages = "876--83",

journal = "Key Obstetrics and Gynecology",

publisher = "Mosby - Year Book, Inc.",

number = "4",

}

TY - JOUR

T1 - Endometrial safety of ultra-low-dose estradiol vaginal tablets

AU - Simon, James

AU - Nachtigall, Lila

AU - Ulrich, Lian G

AU - Eugster-Hausmann, Michaela

AU - Gut, Robert

PY - 2010/10/1

Y1 - 2010/10/1

N2 - To evaluate the endometrial hyperplasia and carcinoma rate after 52-week treatment with ultra-low-dose 10-microgram 17ß-estradiol vaginal tablets in postmenopausal women with vaginal atrophy.

AB - To evaluate the endometrial hyperplasia and carcinoma rate after 52-week treatment with ultra-low-dose 10-microgram 17ß-estradiol vaginal tablets in postmenopausal women with vaginal atrophy.

U2 - 10.1097/AOG.0b013e3181f386bb

DO - 10.1097/AOG.0b013e3181f386bb

M3 - Journal article

VL - 116

SP - 876

EP - 883

JO - Key Obstetrics and Gynecology

JF - Key Obstetrics and Gynecology

IS - 4

ER -